Women's Wellness Blog

 

When One Plus One Equals More Than Two

New research suggests hormone therapy may give weight loss medications a serious boost

Every so often a study comes along that makes me sit up a little straighter in my chair. This is one of those.

Mayo Clinic researchers just published findings in The Lancet showing that postmenopausal women on hormone therapy lost about 35% more weight on tirzepatide (you know it as Zepbound or Mounjaro) than women taking tirzepatide alone.

Let me put that in real numbers. Women using both treatments lost around 17% of their body weight. Women on tirzepatide alone lost 14%. And nearly half of the hormone therapy group hit the 20% weight loss mark, compared to fewer than one in five of the women who weren't on hormones.

That's not a rounding error. That's a meaningful difference.

Why this matters to you

If you're a woman over 40, you already know the plot. Menopause shows up, estrogen packs its bags, and suddenly the same eating and exercise habits that kept you steady for decades stop working. Weight creeps on, especially around the middle. Muscle quietly slips away. And your risk for heart disease and type 2 diabetes climbs right along with the scale.

This isn't a willpower problem. It's a physiology problem. Estrogen does far more than manage your reproductive life. It influences appetite, energy expenditure, and where your body decides to store fat. Take it away and the rules of the game change.

So the idea that restoring estrogen might help a weight loss medication work better isn't crazy. In fact, animal studies suggest estrogen may actually enhance the appetite-suppressing effects of GLP-1 medications. The two may be teammates, not just roommates.

Now for the honest doctor part

This was an observational study of 120 women, not a randomized trial. The researchers themselves were careful to say hormone therapy may not have caused the extra weight loss. It's possible the women on hormone therapy were already living healthier lives. It's also possible that relieving hot flashes and night sweats improved their sleep, which made it easier to stick with better eating and regular movement.

Anyone who has survived months of 3 a.m. night sweats knows that a rested woman makes better choices than an exhausted one. That alone could explain part of the difference.

The good news: the Mayo team plans to test this in a randomized trial, and they want to know whether the combination improves heart and metabolic health beyond just the number on the scale. That's the study I'll be watching for.

My take after 35 years in this business

I've said it before and I'll keep saying it. Hormone therapy is the most effective treatment we have for menopausal symptoms, and for the right woman at the right time, the benefits often extend well beyond hot flash relief. This study adds one more intriguing entry to that list.

Does this mean every woman on a GLP-1 medication should start hormone therapy? No. Hormone therapy is a personalized decision based on your symptoms, your health history, and your goals. Weight loss alone isn't the reason to start it.

But if you're a postmenopausal woman who is a good candidate for hormone therapy anyway, and you're also working on weight with medication, this research suggests the two might play nicely together. That's a conversation worth having with a doctor who actually understands menopause.

The bigger lesson here is one I love: we're finally studying midlife women as midlife women, not as an afterthought. For decades, research treated menopause like a footnote. Now it's getting the attention it deserves, and women are the ones who benefit.

Stay curious. Stay strong. And if your doctor shrugs when you ask about any of this, find one who doesn't.

As always, this is education, not medical advice. Talk with your own physician before starting or changing any treatment.